BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9522581)

  • 1. [Diagnostic criteria of Parkinson's disease and their influence on the prevalence of this disease in population studies].
    Benito-León J; Bermejo F; Molina JA
    Neurologia; 1998 Jan; 13(1):33-9. PubMed ID: 9522581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prevalence of Parkinson disease in an urban area of the Ciudad de La Habana province, Cuba. Door-to-door population study].
    Giroud Benítez JL; Collado-Mesa F; Esteban EM
    Neurologia; 2000; 15(7):269-73. PubMed ID: 11075574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of Parkinson's disease and other types of Parkinsonism. A door-to-door survey in Bidasoa, Spain.
    Bergareche A; De La Puente E; López de Munain A; Sarasqueta C; de Arce A; Poza JJ; Martí-Massó JF
    J Neurol; 2004 Mar; 251(3):340-5. PubMed ID: 15015016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is Parkinson's disease a homogeneous disorder--what is the burden of Parkinson's disease in India.
    Ghosh B; Mishra A; Sengupta P
    J Indian Med Assoc; 2005 Mar; 103(3):146, 148, 150 passim. PubMed ID: 16173291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case ascertainment uncertainties in prevalence surveys of Parkinson's disease.
    Anderson DW; Rocca WA; de Rijk MC; Grigoletto F; Melcon MO; Breteler MM; Maraganore DM
    Mov Disord; 1998 Jul; 13(4):626-32. PubMed ID: 9686765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of parkinsonism and Parkinson's disease in the Arosa Island (Spain): a community-based door-to-door survey.
    Seijo-Martinez M; Castro del Rio M; Rodríguez Alvarez J; Suarez Prado R; Torres Salgado E; Paz Esquete J; Sobrido MJ
    J Neurol Sci; 2011 May; 304(1-2):49-54. PubMed ID: 21402385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The estimation of prevalence of Parkinson disease in Navarra. An epidemiological study of the consumption of anti-parkinsonian drugs].
    Artázcoz Sanz MT; Viñes Rueda JJ
    Rev Esp Salud Publica; 1995; 69(6):479-85. PubMed ID: 8789360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dementia, stroke and Parkinson's disease in Spanish populations: a review of door-to-door prevalence surveys.
    del Barrio JL; de Pedro-Cuesta J; Boix R; Acosta J; Bergareche A; Bermejo-Pareja F; Gabriel R; García de Yébenes MJ; García FJ; López-Pousa S; Manubens JM; Mateos R; Matías-Guiu J; Olivé JM; Reñé R; Rodríguez F; Saz P
    Neuroepidemiology; 2005; 24(4):179-88. PubMed ID: 15832058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parkinsonism and Parkinson's disease in the elderly: a community-based survey in Brazil (the Bambuí study).
    Barbosa MT; Caramelli P; Maia DP; Cunningham MC; Guerra HL; Lima-Costa MF; Cardoso F
    Mov Disord; 2006 Jun; 21(6):800-8. PubMed ID: 16482566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of Parkinson's disease and related disorders in the elderly population of greater Beijing, China.
    Zhang ZX; Anderson DW; Huang JB; Li H; Hong X; Wei J; Yang EL; Maraganore DM
    Mov Disord; 2003 Jul; 18(7):764-72. PubMed ID: 12815655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Estimation of the prevalence of Parkinson's disease in Asturia, Spain. A pharmacoepidemiological study of the consumption of antiparkinson drugs].
    Martínez-Suárez MM; Blázquez-Menes B
    Rev Neurol; 2000 Dec 1-15; 31(11):1001-6. PubMed ID: 11190861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevalence of mental disorders in persons with Parkinson's disease].
    de Rijk C; Bijl RV
    Ned Tijdschr Geneeskd; 1998 Jan; 142(1):27-31. PubMed ID: 9556986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of Parkinson's disease and other types of parkinsonism in the Aeolian Archipelago, Sicily.
    Morgante L; Nicoletti A; Epifanio A; Contrafatto D; Savica R; Lanzafame S; Musolino R; La Spina P; Bonuccelli U; Marconi R; D'Amelio M; Savettieri G; Zappia M
    Parkinsonism Relat Disord; 2008 Nov; 14(7):572-5. PubMed ID: 18325817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of Parkinson's disease in Korea.
    Seo WK; Koh SB; Kim BJ; Yu SW; Park MH; Park KW; Lee DH
    J Clin Neurosci; 2007 Dec; 14(12):1155-7. PubMed ID: 17884509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The prevalence and pharmacological cost of Parkinson's disease in Spain].
    Abasolo-Osinaga E; Abecia-Inchaurregui LC; Fernández-Díaz E; Barcenilla-Laguna A; Bañares-Onraita T
    Rev Neurol; 2006 Dec 1-15; 43(11):641-5. PubMed ID: 17133323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in prevalence and incidence of Parkinson's disease in Japan during a quarter of a century.
    Yamawaki M; Kusumi M; Kowa H; Nakashima K
    Neuroepidemiology; 2009; 32(4):263-9. PubMed ID: 19209006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Geographical difference in Parkinson's disease prevalence within West Scotland.
    Newman EJ; Grosset KA; Grosset DG
    Mov Disord; 2009 Feb; 24(3):401-6. PubMed ID: 19021227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Geographic variations in the prevalence rates of Parkinson's disease in Alberta.
    Svenson LW; Platt GH; Woodhead SE
    Can J Neurol Sci; 1993 Nov; 20(4):307-11. PubMed ID: 8313246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of Parkinson's disease in Northwestern Italy: comparison of tracer methodology and clinical ascertainment of cases.
    Chiò A; Magnani C; Schiffer D
    Mov Disord; 1998 May; 13(3):400-5. PubMed ID: 9613728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Parkinson's disease in Spain.
    Grandas F; Kulisevsky J
    Mov Disord; 2003 Jan; 18(1):87-9. PubMed ID: 12518304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.